|
FAM53C expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.13700004966688E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.5081999810439E-09 |
| Normal-vs-Stage2 |
2.92280000202538E-09 |
| Normal-vs-Stage3 |
9.22430021255138E-10 |
| Normal-vs-Stage4 |
1.57630020147792E-10 |
| Stage1-vs-Stage2 |
6.514000E-01 |
| Stage1-vs-Stage3 |
3.099000E-01 |
| Stage1-vs-Stage4 |
5.393600E-02 |
| Stage2-vs-Stage3 |
7.911800E-01 |
| Stage2-vs-Stage4 |
2.530200E-01 |
| Stage3-vs-Stage4 |
2.951600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.44159995052462E-09 |
| Normal-vs-AfricanAmerican |
5.6637999956699E-08 |
| Normal-vs-Asian |
5.54939999508619E-08 |
| Caucasian-vs-AfricanAmerican |
6.776000E-01 |
| Caucasian-vs-Asian |
7.581600E-02 |
| AfricanAmerican-vs-Asian |
4.151200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.97280003444433E-09 |
| Normal-vs-Female |
1.11309994554887E-09 |
| Male-vs-Female |
7.533200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.411699950855E-09 |
| Normal-vs-Age(41-60Yrs) |
1.81299997237261E-09 |
| Normal-vs-Age(61-80Yrs) |
1.3034995305361E-10 |
| Normal-vs-Age(81-100Yrs) |
1.037980E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.808000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.002000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.390400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.117800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.638400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.205000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.37079999999757E-05 |
| Classical-VS-Follicular |
1.015890E-03 |
| Classical-VS-Other |
5.006800E-01 |
| Classical-VS-Normal |
1.14670000161965E-08 |
| Tall-VS-Follicular |
3.192600E-01 |
| Tall-VS-Other |
4.389400E-01 |
| Tall-VS-Normal |
3.97100130555827E-11 |
| Follicular-VS-Other |
6.886800E-01 |
| Follicular-VS-Normal |
2.1234003444448E-10 |
| Other-VS-Normal |
3.81059999999822E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.90379975409883E-10 |
| Normal-vs-N1 |
1.43140055364199E-10 |
| N0-vs-N1 |
2.121400E-01 |
|
|
